Interferon ?-1b for patients with moderate to severe COVID-19 in the inflammatory phase of the disease - Tortajada C; Añón S; Ortiz MM; Andreu-Ballester JC; Flores J (JOURNAL OF MEDICAL VIROLOGY, 2021)